Skip to main

Scheduled Maintenance - Friday 16 October 2026 from 8:30pm AEST

Maintenance is scheduled between 8:30pm - 11 pm AEST, Friday 16 October 2026 and the site may be unavailable or slow during this time.

Designation of Adalimumab (HUMIRA) as an Orphan Drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2012G0025514 November 2012

Details

Title ID
C2012G00255
Collection
Gazette
Registered
14 November 2012